Denise M. Kenski
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Advanced biosensing and bioanalysis techniques, RNA Interference and Gene Delivery, PI3K/AKT/mTOR signaling in cancer, Protein Kinase Regulation and GTPase Signaling, MicroRNA in disease regulation
Most-Cited Works
- → Systems survey of endocytosis by multiparametric image analysis(2010)457 cited
- → Somatic Mutations in p85α Promote Tumorigenesis through Class IA PI3K Activation(2009)287 cited
- → Phosphospecific proteolysis for mapping sites of protein phosphorylation(2003)239 cited
- → Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold(2004)135 cited
- → A second-site suppressor strategy for chemical genetic analysis of diverse protein kinases(2005)135 cited
- → siRNA-optimized Modifications for Enhanced In Vivo Activity(2012)89 cited
- → Analysis of acyclic nucleoside modifications in siRNAs finds sensitivity at position 1 that is restored by 5′-terminal phosphorylation both in vitro and in vivo(2009)83 cited
- → Chemical genomic profiling to identify intracellular targets of a multiplex kinase inhibitor(2005)61 cited
- → mRNA knockdown by single strand RNA is improved by chemical modifications(2012)44 cited
- → Selective Kinase Inhibition by Exploiting Differential Pathway Sensitivity(2006)27 cited